Desensitization to natalizumab: clinical and immunological observations.
Giuseppe
G
Ribizzi
Donatella
D
Bignardi
Daniele
D
Farinini
Davide
D
Sassos
Riccarda
R
Gentile
Daniela
D
Arecco
Domenica
D
Rizzi
Susanna
S
Voltolini
Carlo
C
Serrati
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects*; D003888:Desensitization, Immunologic / Q000379:methods*; D004342:Drug Hypersensitivity / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007108:Immune Tolerance; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000009:adverse effects*; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D007155:Immunologic Factors